What do you want to do today?
video_library
Watch On Demand
auto_awesome_motion
Discover Series
person_search
Search KOLs
campaign
Meet our Ambassadors
group_work
Meet Societies
handshake
Meet Partners
video_library
OnDemand
auto_awesome_motion
Series
person_search
Faculty
campaign
Ambassa-
dors
group_work
Societies
handshake
Partners

Only logged in users can watch the content

Chat keyboard_arrow_down
Description keyboard_arrow_down
The management of anal fistulas is one of the greatest challenges. The need to preserve continence while permanently eradicating the fistula is the ultimate desired goal. Unfortunately, none of the ever-expanding myriads of treatments is a panacea; high rates of failure and of recurrence are consistently experienced. Regenerative or autologous tissue replacement therapies differ from all other options in encouraging tissue growth rather than destroying, ablating, or excising tissue. This program will demonstrate the role of autologous stem cells and gracilis muscle interposition in the treatment of some of the most challenging fistulas.

  1. Welcome & Introduction – Dr. Steven D. Wexner (USA) 

  2. How Regenerative Medicine is Changing the Treatment of Inflammatory Bowel Disease - Dr. Amy Lightner (USA)

  3. The results of stem cells for fecal incontinence - Dr. Lucia Oliveira (Brazil)

  4. Development of stem cells for fistulas - Dr. Damian Garcia (Spain)

  5. Treating incontinence after fistula surgery – Dr. Liliana Bordeianou (USA)

  6. The results of gracilis interposition for complex perineal fistulas - Dr. Sameh Emile (Egypt)

  7. Video gracilis interposition for rectovaginal and rectourethral fistulas - Dr. Zoe Garoufalia (Greece)

  8. Panel discussion & Closing Remarks  - All faculty moderated by Dr. Steven D. Wexner (USA)

*Supported by an educational grant from Takeda Pharmaceuticals U.S.A.
In collaboration with keyboard_arrow_down
Takeda